Clinical Trial Update: Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated cetuximab plus celecoxib for metastatic colorectal cancer or colorectal cancer that cannot be removed surgically; the study is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)
• Cetuximab (cetuximab)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-11-16